Glycoprotein News and Research

RSS
N501Y mutation and SARS-CoV-2 spike protein-angiotensin-converting enzyme-2 binding

N501Y mutation and SARS-CoV-2 spike protein-angiotensin-converting enzyme-2 binding

1 Sep 2022
Exploration of glycan shield structure of sarbecoviruses provides new insights into developing pan-coronavirus vaccines

Exploration of glycan shield structure of sarbecoviruses provides new insights into developing pan-coronavirus vaccines

30 Aug 2022
How natural alterations inside the SARS-CoV-2 glycan barrier affect spike protein dynamics

How natural alterations inside the SARS-CoV-2 glycan barrier affect spike protein dynamics

22 Aug 2022
GPNMB established as a risk gene and potential therapeutic target for Parkinson's disease

GPNMB established as a risk gene and potential therapeutic target for Parkinson's disease

18 Aug 2022
CD98 identified as a key mediator of pro-fibrotic and acute inflammatory responses in the lung

CD98 identified as a key mediator of pro-fibrotic and acute inflammatory responses in the lung

18 Aug 2022
The impact of the P681H spike mutation in the SARS-CoV-2 Alpha variant

The impact of the P681H spike mutation in the SARS-CoV-2 Alpha variant

17 Aug 2022
What is the potential role of sphingosine kinase inhibitors as antiviral agents?

What is the potential role of sphingosine kinase inhibitors as antiviral agents?

16 Aug 2022
Scientists explore nanomolar inhibition of SARS-CoV-2 infection via unmodified peptide targeting spike protein pre-hairpin intermediate

Scientists explore nanomolar inhibition of SARS-CoV-2 infection via unmodified peptide targeting spike protein pre-hairpin intermediate

15 Aug 2022
Post-illness metabolomic and gut-microbiome profiles in community-dwelling participants with SARS-CoV-2

Post-illness metabolomic and gut-microbiome profiles in community-dwelling participants with SARS-CoV-2

15 Aug 2022
Vaccines and monoclonal antibodies being developed for respiratory syncytial virus

Vaccines and monoclonal antibodies being developed for respiratory syncytial virus

11 Aug 2022
How does the interval between the 1st and 2nd BNT162b2 doses impact the neutralization breadth and potency against variants of concern?

How does the interval between the 1st and 2nd BNT162b2 doses impact the neutralization breadth and potency against variants of concern?

9 Aug 2022
Powerful injectable gel provides hope for preventing glioblastoma relapse

Powerful injectable gel provides hope for preventing glioblastoma relapse

8 Aug 2022
What is the impact of SARS-CoV-2 Omicron BA.2 breakthrough infection on novel Omicron sublineages?

What is the impact of SARS-CoV-2 Omicron BA.2 breakthrough infection on novel Omicron sublineages?

8 Aug 2022
Study suggests peimine may be a potent inhibitor of SARS-CoV-2 variant infection

Study suggests peimine may be a potent inhibitor of SARS-CoV-2 variant infection

2 Aug 2022
The impact of respiratory droplet volume and their evaporation kinetics on environmental stability of respiratory viruses

The impact of respiratory droplet volume and their evaporation kinetics on environmental stability of respiratory viruses

2 Aug 2022
ViruStop, ACROBiosystems’s new brand accelerating the process of vaccine development and approval

ViruStop, ACROBiosystems’s new brand accelerating the process of vaccine development and approval

From ACROBiosystems 1 Aug 2022
A VSV-based COVID vaccine effective against SARS-CoV-2 variants

A VSV-based COVID vaccine effective against SARS-CoV-2 variants

25 Jul 2022
Researchers investigate the feasibility of modifying cholera toxin for targeted delivery to specific organelles

Researchers investigate the feasibility of modifying cholera toxin for targeted delivery to specific organelles

25 Jul 2022
Booster vaccination counters the severity of Omicron breakthrough infections

Booster vaccination counters the severity of Omicron breakthrough infections

21 Jul 2022
Nitazoxanide drug found to be a potent inhibitor of several human coronaviruses

Nitazoxanide drug found to be a potent inhibitor of several human coronaviruses

18 Jul 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback